H-Index
75
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
18%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

Current knowledge on treatment of chronic hepatitis B in children

Dariusz Marek Lebensztejn, Maciej Kaczmarski

Med Sci Monit 2000; 6(1): RA198-203

ID: 508587

Published:


So far the treatment of chronic hepatitis B has been based on the use of numerous agents, particularly interferon alpha which proved the most effective. Attempts are made to introduce new therapeutic methods (antiviral agents - nucleoside analogues, immunotherapy - anti HBV vaccine, gene therapy) in order to obtain higher percentage of patients with durable inhibition of HBV replication than it is observed after treatment with interferon alpha. The current work has been devoted to the presentation of the experiences with interferon alpha, lamivudine and anti HBV vaccine used in subjects with chronic type B hepatitis, with special reference to paediatric patients.

Keywords: anti HBV vaccine, Lamivudine, interferon alpha, chronic hepatitis B



Back